Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

862
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
862
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

494
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
494
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

321
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
321
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

600
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
600
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

271
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
271

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical education in low- and middle-income countries must be innovated without neglecting its foundational principles.

Frontiers in medicine·2026
Same author

Hepatitis D virus infection in sub-Saharan Africa: a scarcely studied, yet important issue.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Long-acting injectable cabotegravir/rilpivirine in a pregnant woman living with HIV with hyperemesis gravidarum:a case report and review of literature.

International journal of STD & AIDS·2026
Same author

Hepatitis C virus and HIV transmission: parenteral (including percutaneous) routes are still relevant and must receive due attention.

Frontiers in public health·2026
Same author

Community acquired bacteremia in older adults: International and prospective infectious diseases-international research initiative (ID-IRI) study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Research priorities for data science and artificial intelligence in global health: an international consensus exercise.

The Lancet. Global health·2026

Related Experiment Video

Updated: Nov 17, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.9K

Mini-review: Silico-tuberculosis.

Massimiliano Lanzafame1, Sandro Vento2

  • 1Diagnosis and Treatment of HIV Infection Unit, "G.B. Rossi University Hospital", Verona, Italy.

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|February 18, 2021
PubMed
Summary

Silicosis significantly increases tuberculosis risk, complicating diagnosis and treatment. Effective prevention strategies, including silica dust reduction and chemoprophylaxis, are crucial for managing this global health challenge.

Keywords:
Low income countriesMinersMiningSilico-tuberculosisSilicosisTuberculosis

More Related Videos

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.0K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.0K

Related Experiment Videos

Last Updated: Nov 17, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.9K
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.0K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.0K

Area of Science:

  • Occupational Health
  • Pulmonary Medicine
  • Infectious Diseases

Background:

  • Silicosis remains a major global health concern, with the 2030 elimination target unlikely to be met.
  • Silicosis patients face a substantially higher risk of developing pulmonary tuberculosis.
  • HIV coinfection exacerbates tuberculosis risk, particularly in specific populations like South African miners.

Purpose of the Study:

  • To highlight the challenges in diagnosing and treating tuberculosis in silicosis patients.
  • To emphasize the critical need for tuberculosis prevention strategies in individuals exposed to silica.
  • To discuss the current limitations and potential expansion of chemoprophylaxis for silico-tuberculosis.

Main Methods:

  • Review of existing literature on silicosis and tuberculosis co-occurrence.
  • Analysis of diagnostic challenges, including the role of chest X-rays and smear examinations.
  • Evaluation of treatment difficulties, recommended therapies, and relapse risks.

Main Results:

  • Diagnosis of active tuberculosis in silicosis patients is often delayed and problematic.
  • Treatment for silico-tuberculosis is complex, requiring prolonged therapy and facing frequent drug reactions and higher relapse rates.
  • Tuberculosis prevention measures, including dust control and chemoprophylaxis, are essential but have limited efficacy.

Conclusions:

  • Silico-tuberculosis presents a persistent and significant global health challenge.
  • Integrated strategies for silica dust exposure reduction, early detection, and effective treatment are imperative.
  • Further research and global efforts are needed to combat silico-tuberculosis effectively.